Literature DB >> 2960678

Separation of the high affinity insulin-like growth factor I receptor from low affinity binding sites by affinity chromatography.

S E Tollefsen1, K Thompson, D J Petersen.   

Abstract

We have identified high and low affinity insulin-like growth factor I (IGF I)-binding sites with mean dissociation constants of 0.37 and 6.25 nM, respectively, in solubilized placental membranes. We have separated these sites and purified the high affinity IGF I receptor 1,300-fold, with an overall yield of 9.9%, using wheat germ agglutinin-Sepharose chromatography, insulin affinity chromatography, and IGF I affinity chromatography. The Scatchard plot of IGF I binding to the high affinity receptor is linear, suggesting the purification of a single homogeneous class of binding sites. Insulin is two orders of magnitude less effective than IGF I in competitively inhibiting IGF I binding to this receptor. The high affinity IGF I receptor is composed of alpha and beta subunits with apparent molecular weights of 135,500 and 96,200, respectively. IGF I at concentrations of greater than or equal to 50 ng/ml stimulates autophosphorylation of the beta subunit of the purified high affinity receptor 4.6-fold. Low affinity IGF I-binding sites run through the IGF I affinity column or are eluted from the insulin affinity column. The separation of IGF I receptors with different binding affinities by sequential affinity chromatography will make it possible to examine directly the determinants of receptor affinity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960678

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Delineation of atypical insulin receptors from classical insulin and type I insulin-like growth factor receptors in human placenta.

Authors:  H A Jonas; A J Cox; L C Harrison
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

2.  Phytosulfokine-alpha, a sulfated pentapeptide, stimulates the proliferation of rice cells by means of specific high- and low-affinity binding sites.

Authors:  Y Matsubayashi; L Takagi; Y Sakagami
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

3.  Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation.

Authors:  S E Tollefsen; J L Sadow; P Rotwein
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

4.  Insulin-like growth factor I receptors of fetal brain are enriched in nerve growth cones and contain a beta-subunit variant.

Authors:  S Quiroga; R S Garofalo; K H Pfenninger
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

5.  Insulin-like growth factor binding to the atypical insulin receptors of a human lymphoid-derived cell line (IM-9).

Authors:  H A Jonas; A J Cox
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

6.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

7.  Importance of receptor occupancy, concentration differences, and ligand exchange in the insulin-like growth factor I receptor system.

Authors:  P Zhong; J F Cara; H S Tager
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Protein phosphotyrosine phosphatase purified from the particulate fraction of human placenta dephosphorylates insulin and growth-factor receptors.

Authors:  J Roome; T O'Hare; P F Pilch; D L Brautigan
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

9.  Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.

Authors:  Y Nakanishi; J L Mulshine; P G Kasprzyk; R B Natale; R Maneckjee; I Avis; A M Treston; A F Gazdar; J D Minna; F Cuttitta
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

10.  High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.

Authors:  G Milazzo; C C Yip; B A Maddux; R Vigneri; I D Goldfine
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.